In breast cancer, although previous studies have found that GCs induce chemotherapy resistance in some types of breast cancer cells4, 11, it remains unclear whether resistance to chemotherapy or other pharmacotherapies is associated with GR expression. Here, NR3C1 is linked to breast carcinoma.